Skip to content

(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.

Robert Oberlender, D E Nichols

Journal of Pharmacology and Experimental Therapeutics December 1, 1990 DOI: 10.1016/s0022-3565(25)22947-0 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Drug discrimination study in rats Peer reviewed
Population Rats trained to discriminate saline from (+)-MBDB
Interventions MDMA 3 (+)-lysergic acid diethylamide 2 5-dimethoxy-4-methylamphetamine mescaline (+)-amphetamine (+)-methamphetamine cocaine 5 6-methylenedioxy-2-aminoindan
Dose 7.18 mumol/kg (1.75 mg/kg) (+)-MBDB hydrochloride
Keywords Animals Rats, inbred strains N-methyl-3,4-methylenedioxyamphetamine Indans Hallucinogens Behavior, animal Learning Dose-response relationship, drug Stereoisomerism Male
Key points The (+)-MBDB discriminative cue generalized to MDMA and MDA with similar stereoselectivity, but not to hallucinogens (LSD, DOM, mescaline) or psychostimulants (amphetamine, methamphetamine); cocaine produced partial substitution. The authors argue this supports a distinct "entactogen" drug class, and that non-neurotoxic MDA analogs (5,6-methylenedioxy-2-aminoindan and its N-methyl derivative) fully substituted for (+)-MBDB, indicating entactogen-like effects can be separated from neurotoxic potential.

Abstract

The stimulus properties of 3,4-methylenedioxymethamphetamine (MDMA)-like compounds were studied in rats trained to discriminate saline from (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine [(+)-MBDB] hydrochloride (7.18 mumol/kg; 1.75 mg/kg), the alpha-ethyl homolog of MDMA. In previous experiments with (+)-MBDB as a test drug, complete substitution was observed for MDMA but not for (+)-lysergic acid diethylamide or (+)-amphetamine. In the study reported here, the (+)-MBDB cue generalized to MDMA and the parent drug, 3,4-methylenedioxyamphetamine. All three drugs exhibited a similar stereoselectivity, the (+)-isomer having potency greater than the (-)-isomer. By contrast, the hallucinogens, (+)-lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine and mescaline and the psychostimulants (+)-amphetamine and (+)-methamphetamine did not substitute for (+)-MBDB. Cocaine produced partial substitution. The results support the hypothesis that the primary behavioral activity of MDMA-like compounds is unlike that of hallucinogens and stimulants and may represent the effects of a novel drug class, given the name entactogens. Although the mechanism of action for the discriminative stimulus properties of MDMA-like compounds is not known, there is evidence that presynaptic serotonergic, but not dopaminergic, mechanisms are critical. Finally, 5,6-methylenedioxy-2-aminoindan a non-neurotoxic 3,4-methylenedioxyamphetamine rigid analog that was previously found to substitute for MDMA but not for (+)-lysergic acid diethylamide was found in the study described here to substitute completely for (+)-MBDB. The N-methyl derivative 5,6-methylenedioxy-2-methylminoindan produced similar results. The demonstration of entactogen-like discriminative stimulus properties, for drugs devoid of neuronal degenerative toxicity potential, serves as evidence of the independent mechanisms for these effects in rats.

Citations in the library

Explore topics